QinetiQ Group plc : An opportune buying point
Entry price | Target | Stop-loss | Potential |
---|
GBX 182.7 |
GBX 0 |
GBX 177.45 |
-100% |
---|
QinetiQ Group shows relatively strong fundamentals and is coming back to attractive prices.
From a fundamental viewpoint, the company seems undervalued relatively to its peers with a "EV/Sales" ratio of 0.83x for this year.
In the recent months, the earnings estimates for the next year have regularly been revised upward by analysts.
With an EPS estimated at GBp 13.21 for this next year, QinetiQ Group is currently paid 13.7 times the results.
QinetiQ Group is oversold because it is near to GBp 179. This situation gives credit to a potential technical rebound. The stock could find new energy if crossing the bullish trend line close to GBp 183 in the coming trading session.
The trading strategy can benefit from the proximity of the strong support currently tested in order to buy QinetiQ Group in a good timing. The first objective is the GBp 193.7 resistance. The potential gain is 6%. Investors might place a stop loss order under the GBp 179 support in order to avoid important losses.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.